Overview Charles River Laboratories provides outsourced preclinical and early-stage drug development services to pharmaceutical and biotech companies and presents as a broadly middle-of-the-pack, industrial-growth services business with neither extreme leverage nor standout margins. Across the dataset, CRL sits at roughly the 50th percentile versus peers on efficiency, growth, leverage, profitabil